1.Hill, K (1996) The demography of menopause. Maturitas 23, 113–127.
2.Schoenaker, D, Jackson, CA, Rowlands, JV et al. (2014) Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol 43, 1542–1562.
3.Davis, SR, Lambrinoudaki, I, Lumsden, M et al. (2015) Menopause. Nat Rev Dis Primers 1, 15004.
4.Edmonds, DK & Dewhurst, JS (2006) Dewhurst's Textbook of Obstetrics and Gynaecology. vol. 7th. Malden, Mass: Blackwell Pub.
5.Sherwood, L (1993) Human Physiology: From Cells to Systems. vol. 2. St. Paul: West Publishing Company.
6.O'Connor, KA, Holman, DJ & Wood, JW (2001) Menstrual cycle variability and the perimenopause. Am J Hum Bio 13, 465–478.
7.Morrison, JH, Brinton, RD, Schmidt, PJ et al. (2006) Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 26, 10332–10348.
8.Harlow, SD, Gass, M, Hall, JE et al. (2012) Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97, 1159–1168.
9.Burger, HG, Hale, GE, Dennerstein, L et al. (2008) Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 15, 603–612.
10.Su, HI & Freeman, EW (2009) Hormone changes associated with the menopausal transition. Minerva Ginecol 61, 483–489.
11.Freeman, EW & Sherif, K (2007) Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 10, 197–214.
12.Gold, EB (2011) The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 38, 425–440.
13.Pines, A (2011) Vasomotor symptoms and cardiovascular disease risk. Climacteric 14, 535–536.
14.Kaczmarek, M (2007) The timing of natural menopause in Poland and associated factors. Maturitas 57, 139–153.
15.Kato, I, Toniolo, P, Akhmedkhanov, A et al. (1998) Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51, 1271–1276.
16.Lawlor, DA, Ebrahim, S & Smith, GD (2003) The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. BJOG 110, 1078–1087.
17.Okeke, TC, Anyaehie, UB & Ezenyeaku, CC (2013) Premature menopause. Ann Med Health Sci Res 3, 90–95.
18.Faubion, SS, Kuhle, CL, Shuster, LT et al. (2015) Long-term health consequences of premature or early menopause and considerations for management. Climacteric 18, 483–491.
19.Sherman, S (2005) Defining the menopausal transition. Am J Med 118, 3–7.
20.Monterrosa-Castro, A, Blümel, JE, Portela-Buelvas, K et al. (2013) Type II diabetes mellitus and menopause: a multinational study. Climacteric 16, 663–672.
21.Sekhar, TVDS, Medarametla, S, Rahman, A et al. (2015) Early menopause in type 2 diabetes – a study from a South Indian tertiary care centre. J Clin Diagn Res 9, OC08-OC10.
22.Dunneram, Y, Greenwood, DC, Burley, VJ et al. (2018) Dietary intake and age at natural menopause: results from the UK Women's Cohort Study. J Epidemiol Community Health 72, 733–740.
23.Purdue-Smithe, AC, Whitcomb, BW, Szegda, KL et al. (2017) Vitamin D and calcium intake and risk of early menopause. Am J Clin Nutr 105, 1493–1501.
24.Parker, J, Hashmi, O, Dutton, D et al. (2010) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65, 225–236.
25.Biela, U (2002) [Determinants of the age at natural menopause]. Przegl Lek 59, 165–169.
26. Bagga, D, Ashley, JM, Geffrey, SP et al. (1995) Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention. Cancer 76, 2491–2496.
27.Karelis, AD, Fex, A, Filion, ME et al. (2010) Comparison of sex hormonal and metabolic profiles between omnivores and vegetarians in pre- and post-menopausal women. Br J Nutr 104, 222–226.
28.Rock, CL, Flatt, SW, Thomson, CA et al. (2004) Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 22, 2379–2387.
29.Nagata, C, Takatsuka, N, Kawakami, N et al. (2000) Association of diet with the onset of menopause in Japanese women. Am J Epidemiol 152, 863–867.
30.Agarwal, A, Gupta, S & Sharma, RK (2005) Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3, 28–28.
31.Ruder, EH, Hartman, TJ, Blumberg, J et al. (2008) Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update 14, 345–357.
32.Ozcan, P, Ficicioglu, C, Yildirim, OK et al. (2015) Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats. Reprod Biomed Online 31, 404–410.
33.Berg, J, Tymoczko, J & Stryer, L (2002) Important derivatives of cholesterol include bile salts and steroid hormones. In Biochemistry, 5th ed. pp. 1085–1103 [Zimmerman, P, editor]. New York: W H Freeman.
34.Zsakai, A, Karkus, Z, Utczas, K et al. (2016) Body fatness and endogenous sex hormones in the menopausal transition. Maturitas 87, 18–26.
35.Ho, SC, Wu, S, Chan, SG et al. (2010) Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond) 34, 1265–1274.
36.Torgerson, DJ, Avenell, A, Russell, IT et al. (1994) Factors associated with onset of menopause in women aged 45–49. Maturitas 19, 83–92.
37.Torgerson, DJ, Thomas, RE, Campbell, MK et al. (1997) Alcohol consumption and age of maternal menopause are associated with menopause onset. Maturitas 26, 21–25.
38.Nagata, C, Takatsuka, N, Inaba, S et al. (1998) Association of diet and other lifestyle with onset of menopause in Japanese women. Maturitas 29, 105–113.
39.Nagel, G, Altenburg, HP, Nieters, A et al. (2005) Reproductive and dietary determinants of the age at menopause in EPIC-Heidelberg. Maturitas 52, 337–347.
40.Martin, LJ, Greenberg, CV, Kriukov, V et al. (2006) Intervention with a low-fat, high-carbohydrate diet does not influence the timing of menopause. Am J Clin Nutr 84, 920–928.
41.Dorjgochoo, T, Kallianpur, A, Gao, YT et al. (2008) Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study. Menopause 15, 924–933.
42.Nagata, C, Wada, K, Nakamura, K et al. (2012) Associations of physical activity and diet with the onset of menopause in Japanese women. Menopause 19, 75–81.
43.Carwile, JL, Willett, WC & Michels, KB (2013) Consumption of low-fat dairy products may delay natural menopause. J Nutr 143, 1642–1650.
44.Boutot, ME, Purdue-Smithe, A, Whitcomb, BW et al. (2018) Dietary protein intake and early menopause in the nurses’ health study II. Am J Epidemiol 187, 270–277.
45.Wang, M, Gong, WW, Hu, RY et al. (2018) Age at natural menopause and associated factors in adult women: findings from the China Kadoorie Biobank study in Zhejiang rural area. PLoS ONE 13, e0195658.
46.Purdue-Smithe, AC, Whitcomb, BW, Manson, JE et al. (2018) A prospective study of dairy food intake and early menopause. Am J Epidemiol, 105, 1493–1501.
47.O'Neill, S & Eden, J (2017) The pathophysiology of menopausal symptoms. Obstet Gynaecol Reprod Med 27, 303–310.
48.Dhanoya, T, Sievert, LL, Muttukrishna, S et al. (2016) Hot flushes and reproductive hormone levels during the menopausal transition. Maturitas 89, 43–51.
49.Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13, 1141–1151.
50.Tavani, A, Ricci, E, La Vecchia, C et al. (2000) Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer. Int J Epidemiol 29, 799–802.
51.Xu, WH, Xiang, YB, Ruan, ZX et al. (2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer 108, 613–619.
52.Travis, RC & Key, TJ (2003) Oestrogen exposure and breast cancer risk. Breast Cancer Res 5, 239–247.
53.Clemons, M & Goss, P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344, 276–285.
54.Mungenast, F & Thalhammer, T (2014) Estrogen biosynthesis and action in ovarian cancer. Front Endocrinol (Lausanne) 5, 192.
55.Wu, AH, Pike, MC & Stram, DO (1999) Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91, 529–534.
56.Nagata, C, Nagao, Y, Shibuya, C et al. (2005) Fat intake is associated with serum estrogen and androgen concentrations in postmenopausal Japanese women. J Nutr 135, 2862–2865.
57.Gaskins, AJ, Mumford, SL, Zhang, C et al. (2009) Effect of daily fiber intake on reproductive function: the BioCycle Study. Am J Clin Nutr 90, 1061–1069.
58.Lethaby, A, Marjoribanks, J, Kronenberg, F et al. (2013) Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 12, Cd001395.
59.Schmidt, M, Arjomand-Wolkart, K, Birkhauser, MH et al. (2016) Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints. Cochrane Database Syst Rev 32, 427–430.
60.Herber-Gast, GC & Mishra, GD (2013) Fruit, Mediterranean-style, and high-fat and -sugar diets are associated with the risk of night sweats and hot flushes in midlife: results from a prospective cohort study. Am J Clin Nutr 97, 1092–1099.
61.Begum, S & A, S (2012) Study of immune profile during different phases of menstrual cycle. IJBMR 3, 1407–1409.
62.Nair, AR & Taylor, HS (2010) The mechanism of menstruation. In Amenorrhea: A Case-Based, Clinical Guide, pp. 21–34 [Santoro, NF and Neal-Perry, G, editors]. New York: Humana Press.
63.Beshay, VE & Carr, BR (2013) Hypothalamic-pituitary-ovarian axis and control of the menstrual cycle. In Clinical Reproductive Medicine and Surgery: A Practical Guide, 2 ed., pp. 31–42 [Falcone, T and Hurd, WW, editors]. New York: Springer.
64.Lengyel, E (2010) Ovarian cancer development and metastasis. Am J Pathol 177, 1053–1064.
65.Fucic, A, Gamulin, M, Ferencic, Z et al. (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health 11, S8-S8.
66.Ogura, K, Irahara, M, Kiyokawa, M et al. (2001) Effects of leptin on secretion of LH and FSH from primary cultured female rat pituitary cells. Eur J Endocrinol 144, 653–658.
67.Azrad, M, Turgeon, C & Demark-Wahnefried, W (2013) Current evidence linking polyunsaturated fatty acids with cancer risk and progression. Front Oncol 3, 224.
68.Larsson, SC, Kumlin, M, Ingelman-Sundberg, M et al. (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935–945.
69.Calder, PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 75, 645–662.
70.Merritt, MA, Cramer, DW, Missmer, SA et al. (2014) Dietary fat intake and risk of epithelial ovarian cancer by tumour histology. Br J Cancer 110, 1392–1401.
72.Berquin, IM, Min, Y, Wu, R et al. (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117, 1866–1875.
73.Wong, RHF & Sul, HS (2010) Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr Opin Pharmacol 10, 684–691.
74.Sul, HS & Wang, D (1998) Nutritional and hormonal regulation of enzymes in fat synthesis: Studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 18, 331–351.
75.Currie, E, Schulze, A, Zechner, R et al. (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18, 153–161.
76.Hillgartner, F, Salati, LM & Goodridge, AG (1995) Physiological and molecular mechanisms involved in nutritional regulation of fatty-acid synthesis. Physiol Rev 75, 47–76.
77.Kaaks, R, Lukanova, A & Kurzer, MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev 11, 1531–1543.
78.Losordo, DW & Isner, JM (2001) Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 21, 6–12.
79.Xu, WH, Matthews, CE, Xiang, YB et al. (2005) Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 161, 939–947.
80.Carlson, MJ, Thiel, KW, Yang, S et al. (2012) Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer. Discov Med 14, 215–222.
81.Goodman, MT, Wilkens, LR, Hankin, JH et al. (1997) Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146, 294–306.
82.World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Available at dietandcancerreport.org.
83.Mulholland, HG, Murray, LJ, Cardwell, CR et al. (2008) Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer 99, 434–441.
84.Yoneda, A, Lendorf, ME, Couchman, JR et al. (2012) Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans. J Histochem Cytochem 60, 9–21.
85.Cleary, MP & Grossmann, ME (2009) Obesity and breast cancer: the estrogen connection. Endocrinology 150, 2537–2542.
86.Malara, NM, Leotta, A, Sidoti, A et al. (2006) Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. Breast 15, 81–89.
87.Bussard, KM, Mutkus, L, Stumpf, K et al. (2016) Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res 18, 84.
88.Llaverias, G, Danilo, C, Mercier, I et al. (2011) Role of cholesterol in the development and progression of breast cancer. Am J Pathol 178, 402–412.
89.Wu, Q, Ishikawa, T, Sirianni, R et al. (2013) 27-Hydroxycholesterol promotes cell-autonomous ER-positive breast cancer growth. Cell Rep 5, 637–645.
90.Baek, AE, Yu, Y-RA, He, S et al. (2017) The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun 8, 864.
91.Derby, CA, Crawford, SL, Pasternak, RC et al. (2009) Lipid changes during the menopause transition in relation to age and weight the study of women's health across the nation. Am J Epidemiol 169, 1352–1361.
92.Lu, D-L, Le Cornet, C, Sookthai, D et al. (2018) Circulating 27-hydroxycholesterol and breast cancer risk: results from the EPIC-Heidelberg cohort. J Natl Cancer Inst 111, 1–7.
93.De Souza, CT, Araujo, EP, Bordin, S et al. (2005) Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199.
94.Orgel, E & Mittelman, SD (2013) The links between insulin resistance, diabetes, and cancer. Curr Diab Rep 13, 213–222.
95.Rose, DP, Gracheck, PJ & Vona-Davis, L (2015) The interactions of obesity, inflammation and insulin resistance in breast cancer. Cancers (Basel) 7, 2147–2168.
96.Mukhopadhyay, KD, Liu, Z, Bandyopadhyay, A et al. (2015) Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells. PLoS ONE 10, e0121136.
97.Daka, B, Rosen, T, Jansson, PA et al. (2013) Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden. Endocr Connect 2, 18–22.
98.Sieri, S, Muti, P, Claudia, A et al. (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 130, 921–929.
99.Howe, LR, Subbaramaiah, K, Hudis, CA et al. (2013) Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res 19, 6074–6083.
100.Key, TJ, Appleby, PN, Reeves, GK et al. (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14, 1009–1019.
101.Chen, G-C, Chen, S-J, Zhang, R et al. (2016) Central obesity and risks of pre- and postmenopausal breast cancer: a dose–response meta-analysis of prospective studies. Obes Rev 17, 1167–1177.
102.Luque, RM, López-Sánchez, LM, Villa-Osaba, A et al. (2017) Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients. Oncotarget 8, 81462–81474.
103.Harris, HR, Cramer, DW, Vitonis, AF et al. (2012) Folate, vitamin B 6, vitamin B 12, methionine and alcohol intake in relation to ovarian cancer risk. Int J Cancer 131, E518-E529.
104.Bandera, EV, Gifkins, DM, Moore, DF et al. (2009) Antioxidant vitamins and the risk of endometrial cancer: a dose–response meta-analysis. Cancer Causes Control 20, 699–711.
105.Donaldson, MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3, 19.
106.Navarro Silvera, SA, Jain, M, Howe, GR et al. (2006) Carotenoid, vitamin A, vitamin C, and vitamin E intake and risk of ovarian cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 15, 395–397.
107.Thomson, CA, Neuhouser, ML, Shikany, JM et al. (2008) The role of antioxidants and vitamin A in ovarian cancer: results from the women's health initiative. Nutr Cancer 60, 710–719.
108.Koushik, A, Wang, M, Anderson, KE et al. (2015) Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies. Cancer Causes Control 26, 1315–1327.
109.Estébanez, N, Gómez-Acebo, I, Palazuelos, C et al. (2018) Vitamin D exposure and risk of Breast Cancer: a meta-analysis. Sci Rep 8, 9039.
110.McCullough, ML, Rodriguez, C, Diver, WR et al. (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 14, 2898–2904.
111.Ahonen, MH, Zhuang, YH, Aine, R et al. (2000) Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86, 40–46.
112.Yu, W, Cline, M, Maxwell, LG et al. (2010) Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/- mice. Cancer Prev Res (Phila) 3, 1246–1258.
113.Cook, LS (2010) A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol 203, 70.e1–8.
114.McCullough, ML, Bandera, EV, Moore, DF et al. (2008) Vitamin D and calcium intake in relation to risk of endometrial cancer: A systematic review of the literature. Prev Med 46, 298–302.
115.Romagnolo, DF & Selmin, OI (2012) Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31, 206.
116.Rossi, M & La Vecchia, C (2014) Flavonoids and the risk of ovarian cancer. Am J Clin Nutr 100, 1217–1219.
117.Cassidy, A, Huang, TY, Rice, MS et al. (2014) Intake of dietary flavonoids and risk of epithelial ovarian cancer. Am J Clin Nutr 100, 1344–1351.
118.Luo, H, Rankin, GO, Li, Z et al. (2011) Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem 128, 513–519.
119.Luo, H, Rankin, GO, Juliano, N et al. (2012) Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NF kappa B-cMyc-p21 pathway. Food Chem 130, 321–328.
120.Hui, C, Qi, X, Qianyong, Z et al. (2013) Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS ONE 8, e54318.